Almudena Castro Conde, Domingo Marzal Martín, Raquel Campuzano Ruiz, Maria Rosa Fernández Olmo, Carlos Morillas Ariño, Juan José Gómez Doblas, Jose Luis Gorriz Teruel, Pilar Mazón Ramos, Xavier García-Moll Marimon, Maria Jose Soler Romeo, David León Jiménez, Vicente Arrarte Esteban, Juan Carlos Obaya Rebollar, Carlos Escobar Cervantes, Juan J Gorgojo Martínez
Type 2 diabetes (T2DM) is one of the main public health care problems worldwide. It is associated with a marked increased risk of developing atherosclerotic vascular disease, heart failure, chronic kidney disease and death. It is essential to act during the early phases of the disease, through the intensification of lifestyle changes and the prescription of those drugs that have been shown to reduce these complications, with the aim not only of achieving an adequate metabolic control, but also a comprehensive vascular risk control...
June 8, 2023: Journal of Clinical Medicine